DWTX Sets 2026 AGM for June 16; Key Votes on Directors, Shares

Key Highlights

• Dogwood Therapeutics (DWTX) will hold its 2026 Annual Meeting of Stockholders virtually on June 16, 2026, at 10:00 a.m. ET.
• Stockholders will vote on the election of seven director nominees.
• Proposal to ratify Forvis Mazars, LLP as the independent auditor for fiscal year ending December 31, 2026.
• Vote to approve an amendment to increase authorized common and preferred stock.
• Advisory vote on the frequency of future Say-on-Frequency votes (Board recommends "1 YEAR").
• Advisory vote on the compensation of named executive officers (Board recommends "FOR").
• The record date for voting eligibility is April 21, 2026.
• Directors and officers beneficially own approximately 0.3% of outstanding common stock.